HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improvement in walking speed in poststroke spastic hemiplegia after intrathecal baclofen therapy: a preliminary study.

AbstractOBJECTIVE:
To explore whether intrathecal baclofen (ITB) therapy improves ambulation in stroke survivors.
DESIGN:
Case series.
SETTING:
Tertiary care center.
PARTICIPANTS:
Ten adults with poststroke hemiparesis who were ambulatory at the time of pump implantation.
INTERVENTIONS:
Implantation of ITB pump after inadequate control of spasticity with other interventions. Time from stroke onset to implantation averaged 28.6 months (range, 9-55mo).
MAIN OUTCOME MEASURES:
Customary walking speed was measured from the time required to walk 50ft (15m) at a self-selected pace. Evaluators rated spastic hypertonia and functional mobility.
RESULTS:
Statistically significant improvements occurred in walking speed, functional mobility ratings, and spasticity (P<.05) at a follow-up interval that averaged 8.9 months. Mean walking speed over 50ft improved from 36.6 to 52cm/s. Mean Modified Ashworth Scale scores in the muscles of the affected lower limb improved from 2.0 to 0.4. Normal muscle strength (5/5) was preserved in the unaffected limbs.
CONCLUSIONS:
This preliminary study suggests that ITB therapy, in combination with physical therapy, may improve walking speed and functional mobility in ambulatory individuals with poststroke spastic hemiplegia.
AuthorsGerard E Francisco, Corwin Boake
JournalArchives of physical medicine and rehabilitation (Arch Phys Med Rehabil) Vol. 84 Issue 8 Pg. 1194-9 (Aug 2003) ISSN: 0003-9993 [Print] United States
PMID12917859 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • Muscle Relaxants, Central
  • Baclofen
Topics
  • Adult
  • Aged
  • Baclofen (administration & dosage, adverse effects)
  • Female
  • Hemiplegia (drug therapy, etiology, rehabilitation)
  • Humans
  • Infusion Pumps, Implantable
  • Injections, Spinal (methods)
  • Male
  • Middle Aged
  • Muscle Relaxants, Central (administration & dosage, adverse effects)
  • Muscle Spasticity (drug therapy, etiology, rehabilitation)
  • Severity of Illness Index
  • Stroke (complications)
  • Stroke Rehabilitation
  • Treatment Outcome
  • Walking (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: